Collateral for a security interest recorded Jan 21, 2026 (Bank of Montreal).
Term ends Oct 16, 2034 · High confidence
20-year base term ends Jun 27, 2034
Held by Normedix, Inc.
Filed Jun 1, 2020 as application 16/889,188 · Granted Sep 3, 2024
Base term plus 111 days of patent term adjustment (USPTO delay)
Today
2014
2034
Clock starts
Jun 27, 2014
Jun 27, 2014
Term ends
Oct 16, 2034
Oct 16, 2034
Granted
Sep 3, 2024
Sep 3, 2024
base term
patent term adjustment
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
111
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 111 days past its 20-year base term on prosecution delay. 0 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 27, 2014, when application PCT/US2014/044519, the earliest non-provisional in its chain, was filed (this one was filed Jun 1, 2020) | Jun 27, 2034 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +111 days, USPTO patent term adjustment record | Oct 16, 2034 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 16, 2034 | High confidence |
This family
| Application PCT/US2014/044519 | PCT application no patent term | no patent term |
| US 9,937,321 | In force Aug 2034 | Aug 2034 |
| US 10,702,674 | In force Feb 2035 | Feb 2035 |
| Application PCT/US2017/033319 | PCT application no patent term | no patent term |
| US 11,013,890 | In force Jun 2034 | Jun 2034 |
| US 12,076,502 | this patent Oct 2034 | Oct 2034 |
| US 12,415,054 | In force Sep 2034 | Sep 2034 |
| Application 19/304,328 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 21, 2023 Reel 63041, frame 661 | Ganske, Karl V.; Welch, Jeffrey M.; Sutton, Gregg Stuart | Normedix, Inc. | Assignment of Assignor's Interest |
| Aug 23, 2024 Reel 68762, frame 423 | Surmodics, Inc.; Surmodics Shared Services, LLC; Surmodics Holdings, LLC; Surmodics Coatings, LLC; Surmodics MD, LLC; Surmodics Coatings MFG, LLC; Surmodics Ivd, Inc.; Surmodics MD Operations, LLC; Normedix, Inc. | Midcap Funding IV Trust | Security Interest |
| Nov 24, 2025 Reel 73690, frame 186 | Midcap Funding IV Trust | Surmodics, Inc.; Surmodics Shared Services, LLC; Surmodics Holdings, LLC; Surmodics Coatings, LLC; Surmodics MD, LLC; Surmodics Coatings MFG, LLC; Surmodics Ivd, Inc.; Surmodics MD Operations, LLC; Normedix, Inc. | Release of Security Interest |
| Nov 24, 2025 reel/frame not recorded | Midcap Funding IV Trust | Surmodics, Inc. | Release of Security Interest |
| Nov 24, 2025 reel/frame not recorded | Midcap Funding IV Trust | Surmodics Shared Services, LLC | Release of Security Interest |
| Nov 24, 2025 reel/frame not recorded | Midcap Funding IV Trust | Surmodics Holdings, LLC | Release of Security Interest |
| Nov 24, 2025 reel/frame not recorded | Midcap Funding IV Trust | Surmodics Coatings, LLC | Release of Security Interest |
| Nov 24, 2025 reel/frame not recorded | Midcap Funding IV Trust | Surmodics MD, LLC | Release of Security Interest |
| Nov 24, 2025 reel/frame not recorded | Midcap Funding IV Trust | Surmodics Coatings MFG, LLC | Release of Security Interest |
| Nov 24, 2025 reel/frame not recorded | Midcap Funding IV Trust | Surmodics Ivd, Inc. | Release of Security Interest |
| Nov 24, 2025 reel/frame not recorded | Midcap Funding IV Trust | Surmodics MD Operations, LLC | Release of Security Interest |
| Nov 24, 2025 reel/frame not recorded | Midcap Funding IV Trust | Normedix, Inc. | Release of Security Interest |
| Jan 21, 2026 Reel 74461, frame 199 | Surmodics MD, LLC | Bank Of Montreal, As Collateral Agent | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Oct 2034
Term ends Oct 16, 2034. Maintenance fees still fall due before then
Note
The 111 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
2
later US patents cite this one
Fewer than half of the utility patents granted in 2024 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.